Wilmington Trust’s iShares Biotechnology ETF IBB Stock Holding History

Wilmington Trust’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$990K	Buy	11,553 +1,500	+15%	+$118K	0.02%	388
2014 Q1	$792K	Buy	10,053 +1,350	+16%	+$112K	0.01%	417
2013 Q4	$658K	Buy	8,703 +525	+6%	+$37.2K	0.01%	458
2013 Q3	$572K	Sell	8,178 -1,440	-15%	-$94.3K	0.01%	462
2013 Q2	$558K	Buy	+9,618	New	+$556K	0.01%	446

Other funds holding IBB

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Wilmington Trust's IBB Position: Q2 2014 in Review

Wilmington Trust increased its iShares Biotechnology ETF (IBB) stake by 15% in Q2 2014, buying an estimated $118K and bringing the position to 11,553 shares worth $990K. The position accounts for 0.02% of the portfolio, ranked #388.

Wilmington Trust first reported a position in IBB in Q2 2013 and has held it in 5 quarters since. 307 funds tracked by Wall St. Rank hold IBB as of Q2 2014.

Wilmington Trust held 11,553 shares of iShares Biotechnology ETF worth $990K as of Q2 2014.
Wilmington Trust bought 1,500 iShares Biotechnology ETF shares in Q2 2014, an estimated $118K.
iShares Biotechnology ETF made up 0.02% of Wilmington Trust's portfolio in Q2 2014, its #388 holding.
Wilmington Trust first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 5 quarters since.
307 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.